Stephanie Guild from Robinhood, NewEdge’s Cameron Dawson and Ayako Yoshioka of the Wealth Enhancement Group break down their predictions for the market this year. Plus, star investor Benchmark’s Bill Gurley weighs in on the drama between Elon Musk and Sam Altman. And, shares of Novo Nordisk jumped in today’s session on some critical obesity drug data. We explain all the details and what it could mean for the rest of the GL-P1 space.